Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: Prospective case-control study

British Medical Journal

Volumn 316, Issue 7131, 1998, Pages 577-582

  Otto, Markus ^a   Wiltfang, Jens ^b   Schütz, Ekkehard ^a   Zerr, Inga ^a   Otto, Anke ^a   Pfahlberg, Annette ^c   Gefeller, Olaf ^a   Uhr, Manfred ^b   Giese, Armin ^a   Weber, Thomas ^a   Kretzschmar, Hans A ^a   Poser, Sigrid ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Laboratory Diagnosis of CJD

^c Department of Medical Statistics ^*

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S 100;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; NEUROPATHOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 6844255891     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7131.577     Document Type: Article

References (28)

1. Brown P, Gibbs CJJ, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Araro/1991;35:513-29.
2. Alperovitch A, Brown P, Weber T, Pocchiari M, I lofman A, Will RG. The incidence of Creutzfeldt-Jakob disease in Europe in 1993. Lancet 1991;334:918.
3. Kretzschmar H, Ironside J, DeArmond S, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996;53:913-20.
4. Hill AF, Zeidler M, Ironside J, CoIIinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997 49:99-100.
5. Masters CI, I larris JO, Gajdusek DC, Gibbs CJJ, Bernoulli C, Asher DM. Crcutzfeldt-jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979;5:177-88.
6. Steinlioff BJ, Räcker S, Herrendorf G, Poser S, Grosche S, Zerr I, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neural 1996p3:162-6.
7. Jiiui T, Wakayama Y, Shibuya S, Nakata H, Tomaru T, Takahashi Y, et al. High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin Chim Acta 1992;21137-46.
8. Zerr I, Bodemer M, Racker S, Grosche S, Poser S, Kretzschmar HA, et al Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995 45:1609-10.
9. Otto M, Stein H, Szudra A, Zerr I, Bodemer M, Gefeller O, et al. S-100 protein concentrations in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease./Neural 1997;244:56G-70.
10. Otto M, Wiltfang J, Tiimani H, Zerr I, Lantsch M, Kornhuber J, et al. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 1997;225:210-2.
11. HsichG.KenneyK, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N EnglJ Med 1996;33a:924-30.
12. Zerr I, Bodemer M, Otto M, Poser S, Windl O, Kretzsclimar H, et aL Diagnosis of Creutzfeldtjakob disease by two dimensional gel electrophoresis of cerebrospinal fluid. Lancet 1996;348:846-9.
13. Will RG, Zeidler M, Brown P, Harrington M, Lee KH, Kenney KL, Cerebrospinal-fluid test for new variant Creutzfeldt-Jakob disease. Lanctt 1996;348:955.
14. Isobe T, Takahashi K, Okuyama T. S l OOaO (alpha alpha) protein is present in neurons of the central and peripheral nervous system, y Neurochem 1984;43:1494-6.
15. Kindblom L-G, Lodding P, Rosengren L, BaudierJ, Haglid K. S-100 protein in melanocytic tumors. Acta Pathol Microbiol Immunol Scand 1984;92:219-30.
16. Pcrsson L, Hardemark HG, Gustafsson G, Rundstrom G, Mendel-Hartvig I, Esscher T, et al. S100 protein and neuron-specific enolase in cerebrospinal fluid and serum: marker of cell damage in human central nervous system. Stroke 1987;18:911-8.
17. Ingebrichtsen T, Romner B, Kongstad P, Langbakk B. Increased serum levels of protein S100 after minor head injury: a biochemical serum marker with prognostic value? J Neural Keurosurg Psychiatry 1995:59:103-4.
18. Usui A, Kato K, Abe T, Murase M, Tanaka M, Takeuclii E. S l OOaO protein in blood and urine during open heart surgery. Clin Chrm 19S9;35:1942-4.
19. Weber T, Poser S, Zerr I, Racker S, Behring B, Bogumil T, et aL Epidemiology and early diagnosis of human prion diseases. J Neurol 1995; 242:257.
20. Will KG. Epidemiology of Creuufeldt-Jakob disease. Br Med Bull 1993;49:960-70.
21. Windl O, Dempster M, Estibeiro JP, Lathe R, de Suva R, Esmonde T, et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 1996;98:259-64.
22. Vollset SE Confidence intervals for a binominal proportion. Stal Med 1993:12:809-24.
23. Youden WJ. Index rating for diagnostic tests. Confer 1950;3:32-5.
24. Metz CE. Basic principles of ROC analysis. Semin Xucl Med 1978;8:283-98.
25. Lee KH, Harrington MG. Premortem diagnosis of Creutzfeldt-Jakob disease by cerebrospinal fluid diagnosis. Lancet 199G;348:887.
26. Moussavian M, Potolicchio S, Jones R. The 14-3-3 brain protein and transmissible spongiform encephalopathy. NEnglJMed 1997 36:873-4.
27. Astudillo R, Van der Linden J, Radegran K, Hansson L-O, Aberg B. Elevated serum levels of S100 after deep hypothermie arrest correlate with duration of circulatory arrest EurJ Cardiothorac Surg 1996;! 0:1107-13.
28. Jensen R, Marshak DR, Anderson C, Lukas TJ, Vatterson DM. Characterization of human brain S100 protein fraction: amino acid sequence of S100 bet Z J Neurochem 1985;45:700-5.